Return On Assets of Nuvectis Pharma, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nuvectis Pharma, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Nuvectis Pharma, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -91%, a 12% increase year-over-year.
  • Nuvectis Pharma, Inc. annual Return On Assets for 2024 was -103%, a 4.6% increase from 2023.
  • Nuvectis Pharma, Inc. annual Return On Assets for 2023 was -108%, a 8.9% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Nuvectis Pharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -91% +13% +12% 01 Jul 2025 30 Sep 2025
Q2 2025 -95% +11% +11% 01 Apr 2025 30 Jun 2025
Q1 2025 -96% +8% +8.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -103% +5% +4.6% 01 Oct 2024 31 Dec 2024
Q3 2024 -104% +3% +2.4% 01 Jul 2024 30 Sep 2024
Q2 2024 -106% -3% -2.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -104% +3% +2.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -108% -9% -8.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -107% -14% -15% 01 Jul 2023 30 Sep 2023
Q2 2023 -103% 01 Apr 2023 30 Jun 2023
Q1 2023 -107% 01 Jan 2023 31 Mar 2023
Q4 2022 -99% 01 Oct 2022 31 Dec 2022
Q3 2022 -92% 01 Jul 2022 30 Sep 2022

Nuvectis Pharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -103% +5% +4.6% 01 Jan 2024 31 Dec 2024
2023 -108% -9% -8.9% 01 Jan 2023 31 Dec 2023
2022 -99% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.